Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014404
Basic Information
VIS ID
TVIS30014404
Fusion event
HIV-MPZL3 integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr11
Cytoband
q23.3
Reference genome
GRCh37/hg19
Start
118117514/118246799 (Hg38)
End
118117514/118246799 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA11B
Target gene
MPZL3
miRNAs that regulate target gene
hsa-mir-4436b-5p
;
hsa-mir-664b-3p
;
hsa-mir-579-3p
;
hsa-mir-5696
;
hsa-mir-671-5p
;
hsa-mir-4729
;
hsa-mir-4786-3p
;
hsa-mir-449b-3p
;
hsa-mir-1228-3p
;
hsa-mir-1273g-3p
;
hsa-mir-1827
;
hsa-mir-1910-3p
;
hsa-mir-2467-3p
;
hsa-mir-3612
;
hsa-mir-377-5p
;
hsa-mir-4257
;
hsa-mir-4459
;
hsa-mir-455-3p
;
hsa-mir-4695-5p
;
hsa-mir-4793-3p
;
hsa-mir-508-5p
;
hsa-mir-6086
;
hsa-mir-6499-3p
;
hsa-mir-650
;
hsa-mir-6511a-5p
;
hsa-mir-6516-5p
;
hsa-mir-665
;
hsa-mir-6807-5p
;
hsa-mir-766-3p
;
hsa-mir-7703
Nearest miRNA
hsa-mir-10392/Upstream/4796711; hsa-let-7a-2/Downstream/397201;
Nearest TSS
ENST00000527297/Upstream/21705;
ENST00000529713/Downstream/5521;
Nearest CpG islands
None/Target,
chr11-CpG: 30/Upstream/93320
,
chr11-CpG: 22/Downstream/112650
Upstream sequence
tcagcctcccaaatagctgagaccacaggcgtgtgccaccacacctggctaattttttgtatttttggtagagacggggtttccctatgttgcctagtct
Downstream sequence
ggactcaaactcctgaactcaggcaatcctcccatctcaacctctcaaagtgctgggattacaggcgtgagccaccatgcttagcctaggccacttttcg
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate